Gerard Cox

12.0k citations
145 papers · 9.6k · 4 hit papers · h-index 47

Impact in

  • Physiology top 0.5%
    • Asthma and respiratory diseases
    • Respiratory and Cough-Related Research
    • Chronic Obstructive Pulmonary Disease (COPD) Research
    • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
    • Inhalation and Respiratory Drug Delivery
    • Neonatal Respiratory Health Research
    • Respiratory Support and Mechanisms

Papers in

    • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 36
    • Respiratory and Cough-Related Research 19
    • Chronic Obstructive Pulmonary Disease (COPD) Research 15
    • Inhalation and Respiratory Drug Delivery 11
    • Neonatal Respiratory Health Research 4
    • Asthma and respiratory diseases 47
    • Sarcoidosis and Beryllium Toxicity Research 5

Gerard Cox

140 papers receiving 9.2k citations

Gerard Cox's Hit Papers

Safety, tolerability, and efficacy of pirfenidone in patients with rheumatoid arthritis-associated interstitial lung disease: a randomised, double-blind, placebo-controlled, phase 2 study 2022 · 156 citations
1560+9+18Years since publication4008001.2k

Peers

Gerard Cox
Comparison fields: 5 of 151
  • Physiology 3.8k
  • Pulmonary and Respiratory Medicine 4.5k
  • Immunology and Allergy 508
  • Immunology 1.6k
  • Emergency Medical Services 267
Replace Michel Laviolette with:
Michel Laviolette Canada
Akio Niimi Japan
William R. Henderson United States
Paola Rogliani Italy
Robert McL. Niven United Kingdom
Roland Buhl Germany
Marc B. Hershenson United States
Lewis J. Smith United States
Nick H.T. ten Hacken Netherlands
Benoît Wallaert France
Gerard Cox relative to Michel Laviolette Canada Michel Laviolette's profile →
Citations per field
00.5×1.5×
Michel Laviolette · 1×
Citations per year

Countries citing papers authored by Gerard Cox

Since Specialization
Citations

This map shows the geographic impact of Gerard Cox's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gerard Cox with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gerard Cox more than expected).

Fields of papers citing papers by Gerard Cox

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gerard Cox. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gerard Cox. The network helps show where Gerard Cox may publish in the future.

Co-authors

The 25 scholars most cited alongside Gerard Cox, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Gerard Cox Line = papers co-authored together Gerard Cox links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 145 papers — load more, or switch the sort, to bring in the rest.

#Work
1
IL-6 is an antiinflammatory cytokine required for controlling local or systemic acute inflammatory responses.
Hit paper breakdown →
19981265
2
Tiotropium in combination with placebo, salmeterol, or fluticasone-salmeterol for treatment of chronic obstructive pulmonary disease: a randomized trial.
Hit paper breakdown →
2007541
3 2009541
4 1995450
5 2007449
6
Circulating Fibrocytes Are an Indicator of Poor Prognosis in Idiopathic Pulmonary Fibrosis
Hit paper breakdown →
2009436
7 2007328
8 1995321
9 2013233
10 2006224
11 1992173
12
Safety, tolerability, and efficacy of pirfenidone in patients with rheumatoid arthritis-associated interstitial lung disease: a randomised, double-blind, placebo-controlled, phase 2 study
Hit paper breakdown →
2022156
13 1993154
14 2003153
15 2004150
16 1997135
17 1991135
18 1998134
19 1996133
20 2011131

About Gerard Cox

Gerard Cox is a scholar working on Pulmonary and Respiratory Medicine, Physiology, Immunology, Immunology and Allergy and Endocrine and Autonomic Systems, having authored 145 papers that have together received 9.6k indexed citations. Recurring topics across this work include Asthma and respiratory diseases (47 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (36 papers), Respiratory and Cough-Related Research (19 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (15 papers), Inhalation and Respiratory Drug Delivery (11 papers), Immune Response and Inflammation (10 papers), Sarcoidosis and Beryllium Toxicity Research (5 papers) and Neonatal Respiratory Health Research (4 papers). The work is most often cited by research in Physiology (3.8k citations), Pulmonary and Respiratory Medicine (4.5k citations), Immunology and Allergy (508 citations), Immunology (1.6k citations) and Emergency Medical Services (267 citations). Gerard Cox has collaborated with scholars based in Canada, United States and Australia. Frequent co-authors include Jack Gauldie, Manel Jordana, Heinz Baumann, John D. Miller, Michel Laviolette, Zheng Xing, Adalberto Sperb Rubin, Robert McL. Niven, Neil C. Thomson and Paul A. Corris. Their work appears in journals such as American Journal of Respiratory and Critical Care Medicine, CHEST Journal, European Respiratory Journal, American Journal of Respiratory Cell and Molecular Biology and Journal of Allergy and Clinical Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact